Mesquida M, Leszczynska a, Llorenç V, Adán a (2014) interleucina-6 bloqueo en la enfermedad inflamatoria ocular. Clin Exp Ophthalmol 176: 301-309.
Cronau H (2010) diagnóstico y manejo de ojos rojos en Atención Primaria. Am Fam Physician 81: 137-144.
Song J, Huang YF, Zhang WJ, Chen XF, Guo YM (2016) enfermedades oculares: mecanismos inmunológicos y moleculares. Int J Ophthalmol 9: 780-788.,
Bora NS, Gobleman CL, Atkinson JP, Pepose JS, Kaplan HJ (1993) Differential expression of the complement regulatory proteins in the human eye. Invest Ophthalmol Vis Sci 34: 851-855.
Jha P, Bora PS, Bora NS (2007) el sistema del complemento y las enfermedades oculares. Mol Immunol 44: 3901-3908.
Bielory L, Katelaris CH, Lightman s, Naclerio RM (2007) tratamiento del componente ocular de la rinoconjuntivitis alérgica y trastornos oculares relacionados. MedGenMed 9: 35-46.
Behlau I, Gilmore MS (2008) Microbial biofilms in ophthalmology and infectious disease., Arch Ophthalmol 126: 1572-1581. Szczotka-Flynn L, Imamura y, Chandra J, Yu C, Mukherjee PK, et al. (2009) Increased resistance of contact lens-related bacterial biofilms to anti-microbial activity of soft contact lens care solutions. Cornea 28: 918-926.
Mukherjee P (2005) Candida biofilm: a well-designed protected environment. Med Mycol 43: 191-208.